Cryogenics

CryoPreservation Life

CryoPreservation Life Raises $480M Series C for Revolutionary Cryogenics Technology

$480M
Total Raised
Series C
Latest Round
2020
Founded
420
Employees
Scottsdale, AZ
2 min read

Quick Facts

Valuation
$7.2B
Latest Round Size
$480M
Latest Round Date
September 2025

CryoPreservation Life

Advanced cryopreservation technology for organ storage, life extension research, and suspended animation for space travel applications.

$480M
Series C
Valuation
$7.2B
Headquarters
Scottsdale, AZ
Team Size
420
Sector
Life Sciences

Revolutionary Technology

CryoPreservation Life has achieved a groundbreaking $480M Series C funding round, reaching a remarkable valuation of $7.2B. This extraordinary investment represents one of the most ambitious technological ventures of September 2025, positioning the company to advance organ preservation technology, develop space hibernation systems, and expand cryogenic storage facilities globally.

Innovation Breakthrough

Advanced cryopreservation technology for organ storage, life extension research, and suspended animation for space travel applications.

Strategic Investment Focus

Advance organ preservation technology, develop space hibernation systems, and expand cryogenic storage facilities globally

Market Transformation

The cryogenics sector is experiencing unprecedented innovation in 2025, with CryoPreservation Life leading the charge in developing technologies that were once considered science fiction. This funding enables the company to accelerate research and development, bringing revolutionary capabilities closer to commercial reality.

Future Vision

With this substantial investment, CryoPreservation Life is positioned to fundamentally reshape our understanding of what's technologically possible. The company's research could have far-reaching implications across multiple industries and potentially transform human civilization itself.

Visionary Investors

  • • Alcor Life Extension
  • • Cryonics Institute
  • • SpaceX Medical
  • • NASA Innovation

Research Leaders

  • • Cryogenics Pioneer
  • • Dr. Life Extension

Investment Timeline

Series B
$280M
2024-05-15
Series A
$140M
2023-11-20
Seed
$60M
2023-04-18

Technological Impact

🔬 Scientific Breakthrough

CryoPreservation Life represents cutting-edge research that pushes the boundaries of current scientific understanding and technological capabilities.

🌍 Global Impact

The implications of this technology extend far beyond commercial applications, potentially affecting fundamental aspects of human civilization.

🚀 Future Readiness

Investment in CryoPreservation Life represents preparation for a future where today's impossibilities become tomorrow's realities.

⚠️ Speculative Technology Notice

CryoPreservation Life operates in highly experimental and speculative technology areas. While the funding and research are real, the timeline and feasibility of commercial applications remain uncertain. Investment in such ventures carries significant risks alongside potentially transformational rewards.

September 2025 Innovation Leadership

CryoPreservation Life's $480M funding round exemplifies the extraordinary ambition and investment flowing into breakthrough technologies in September 2025. As humanity stands at the threshold of unprecedented technological advancement, companies like CryoPreservation Life are pioneering the research and development that could define the next century of human progress.

Key Investors

Alcor Life Extension
Strategic Research Investor
Leading investor in breakthrough Cryogenics and advanced technology research
Cryonics Institute
Strategic Research Investor
Leading investor in breakthrough Cryogenics and advanced technology research
SpaceX Medical
Strategic Research Investor
Leading investor in breakthrough Cryogenics and advanced technology research
NASA Innovation
Strategic Research Investor
Leading investor in breakthrough Cryogenics and advanced technology research

About the Author

Editorial Team
Editorial Team
The Editorial Team at The Report provides comprehensive coverage of the latest funding rounds and startup ecosystem developments.